Your Partner from Targets to Therapeutics

I wanted to express our sincere gratitude for your invaluable collaboration. Your support and dedication have significantly contributed to our project timeline. We truly appreciate your professionalism and look forward to more opportunities to collaborate in the near future. Thank you once again for your exceptional support.

Since 2021, we have developed five different B-NDG hIL6 models with Biocytogen to support Be Bio's development pipeline (Fabre, MPS-IV, Niemann Pick A/B, Hemophilia B, and Hypophosphatasia). We view Biocytogen's capabilities as complementary to Be Bio's, and a strong partnership will enable us to leverage your strengths to advance our current and future drug development programs.

Biocytogen's gene targeting services have always been professional, efficient and productive. The services have helped us to achieve our goal.